The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with untapped research chemicals showing promising results in preclinical and clinical trials. These molecules often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential advantages for patients struggling with anx